顯示第 2001 至 2016 項結果,共 6874 項
-
Anti-EPHA3 [FA225-C10] (Ab02647-1.1-BT)
-
Anti-EPHA3 [FA225-C10] (Ab02647-1.1)
-
Anti-EPHA3 [FA225-C10] (Ab02647-10.0-BT)
-
Anti-EPHA3 [FA225-C10] (Ab02647-10.0)
-
Anti-EPHA3 [FA225-C10] (Ab02647-10.3-BT)
-
Anti-EPHA3 [FA225-C10] (Ab02647-10.3)
-
Anti-EPHA3 [FA225-C10] (Ab02647-23.0-BT)
-
Anti-EPHA3 [FA225-C10] (Ab02647-23.0)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.0)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.26-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.26)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.3-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.3)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.6-BT)
-
Anti-erbB-2 (Her-2/neu) [4D5-8 (trastuzumab)] (Ab00103-10.6)
